As many as 20% of patients with community-acquired pneumonia (CAP) worsen despite guideline-adherent antimicrobial therapy; in fact, some cases are caused by viruses (NEJM JW Gen Med Sep 1 2015 and N Engl J Med 2015; 373:415). Systemic corticosteroids might reduce the cytokine and inflammatory responses that can lead to some CAP treatment failures. In two recent randomized controlled trials, researchers found outcome improvements with steroid therapy (NEJM JW Infect Dis Mar 2015 and Lancet 2015; 385:1511; NEJM JW Infect Dis Apr 2015 and JAMA 2015; 313:677); however, these trials were not powered to detect mortality differences.